Recently, we reported that TME cell-derived CB2 promotes tumor growth in an experimental model of non-small cell lung cancer (NSCLC) by reducing accumulation and cytotoxic activity of CD8+ T and NK cells. The gene discussed is CNR2; the disease is non-small cell lung carcinoma.